Effects of Lentil Consumption on Post-prandial Blood Glucose and Insulin

NCT02426606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-10-25

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of consuming various lentil varieties in mixed-meals (containing either white rice or white potato) on post-prandial blood glucose and insulin as compared to white rice or white potato alone.

Conditions

  • Healthy

Interventions

OTHER

Various lentil varieties (varying in slow digested starch content)

Randomized, cross-over block design. Comparison of glycemic and insulinemic responses following meals composed of: * white rice or white rice combined with 1 of 3 different lentil varieties or * white potato or white potato combined with 1 of 3 different lentil varieties Participants with be assigned to either the white rice or white potato group. Meals will provide 50g available carbohydrate (AC). In meals containing lentils, whole cooked lentils will provide 25g AC either white rice or white potato will provide 25g AC. Meals will be randomly consumed across 6 study visits, with 2 white bread control meals (one of which will take place on the first visit).

Sponsors & Collaborators

  • Agriculture and Agri-Food Canada

    collaborator OTHER_GOV
  • Pulse Canada

    collaborator OTHER
  • Saskatchewan Pulse Growers

    collaborator OTHER
  • University of Guelph

    lead OTHER

Principal Investigators

  • Alison M Duncan, Ph.D, R.D · University of Guelph

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02426606 on ClinicalTrials.gov